Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDI-COS ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   12.3% 8.2% 8.1% 14.0% 11.5% 11.5% 8.0% 8.0%   Credit score (0-100)   20 31 30 14 20 16 8 8   Credit rating   B B B B B B B B   Credit limit (kDKK)   0.0 0.0 0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   109 110 110 0 0 0 0 0   Gross profit   -9.4 12.9 12.9 -59.8 -97.0 -40.9 0.0 0.0   EBITDA   -9.4 12.9 12.9 -59.8 -97.0 -40.9 0.0 0.0   EBIT   -9.4 12.9 12.9 -65.2 -97.0 -40.9 0.0 0.0   Pre-tax profit (PTP)   -9.4 12.9 12.9 -65.2 -97.0 -40.9 0.0 0.0   Net earnings   -9.4 12.9 12.9 -65.2 -97.0 -40.9 0.0 0.0   Pre-tax profit without non-rec. items   -9.4 12.9 12.9 -65.2 -97.0 -40.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   30.9 43.8 43.8 -3.8 -101 -142 -317 -317   Interest-bearing liabilities   0.0 0.0 0.0 127 127 127 318 318   Balance sheet total (assets)   42.3 60.1 60.1 203 152 77.7 1.0 1.0   Net Debt   -14.9 -30.6 -30.6 82.8 92.3 113 318 318     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   109 110 110 0 0 0 0 0   Net sales growth   -37.1% 1.1% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -9.4 12.9 12.9 -59.8 -97.0 -40.9 0.0 0.0   Gross profit growth   17.3% 0.0% 0.0% 0.0% -62.3% 57.9% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   42 60 60 203 152 78 1 1   Balance sheet change%   -9.4% 42.0% 0.0% 237.5% -25.3% -48.7% -98.7% 0.0%   Added value   -9.4 12.9 12.9 -59.8 -91.6 -40.9 0.0 0.0   Added value %   -8.7% 11.7% 11.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 47 0 -52 0 0   Net sales trend   -1.0 1.0 0.0 -1.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   -8.7% 11.7% 11.7% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   -8.7% 11.7% 11.7% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.2% 100.0% 100.0% 109.1% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   -8.7% 11.7% 11.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -8.7% 11.7% 11.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   -8.7% 11.7% 11.7% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -21.2% 25.1% 21.4% -48.9% -42.3% -17.3% 0.0% 0.0%   ROI %   -26.5% 34.5% 29.4% -76.5% -76.6% -32.2% 0.0% 0.0%   ROE %   -26.5% 34.5% 29.4% -52.9% -54.8% -35.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   73.0% 72.8% 72.8% -1.8% -40.0% -64.6% -99.7% -99.7%   Relative indebtedness %   10.5% 14.8% 14.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   -3.2% -13.0% -13.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   158.0% -237.9% -237.9% -138.6% -95.1% -277.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% -3,357.2% -125.3% -89.2% -100.3% -100.3%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   1.9 2.3 2.3 0.3 0.2 0.1 0.0 0.0   Current Ratio   3.6 3.6 3.6 0.7 0.4 0.3 0.0 0.0   Cash and cash equivalent   14.9 30.6 30.6 43.9 34.5 13.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   21.6 21.1 21.1 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   29.5 59.4 59.4 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   38.0% 53.7% 53.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   29.9 42.8 42.8 -56.9 -154.3 -143.0 -159.0 -159.0   Net working capital %   27.4% 38.8% 38.8% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0